SteveNuyts

Associate

Bruxelles + 32.2.645.15.19

Collegati

Condividi

Steve Nuyts advises and represents Belgian and international companies on all aspects of corporate law, with a focus on M&A, private equity, and venture capital transactions. He also advises clients on corporate restructurings and reorganizations and corporate governance.

Esperienze

  • Biobest acquires BiotropJones Day represented Biobest Group NV, a Belgian developer of biological crop-protection products in its €500 million capital and debt raise for the acquisition of Biotrop Participacoes SA, a provider of biological and natural farming solutions in Brazil, for an enterprise value of about €532 million.
  • Partech Partners leads $37 million Series B financing of SustainCert SAJones Day represented Partech Partners as lead investor with Hartree Partners and existing shareholders, such as the Microsoft Climate Innovation Fund, in the $37 million Series B financing of SustainCert SA, to support the climatetech in scaling its impact verification solution for carbon markets and Scope 3 emissions.
  • JENSEN-GROUP and MIURA create heavy-duty laundry joint venture in JapanJones Day advised JENSEN-GROUP in the formation of a joint venture with MIURA whereby the JENSEN-GROUP acquired 49% of the shares of Inax Corporation, one of the main manufacturing and distribution companies for heavy-duty laundry equipment in Japan and a Japanese wholly owned subsidiary of MIURA, and MIURA took a 20% stake in the JENSEN-GROUP through a combination of 49% of the shares of Inax and an add-on capital increase in cash.
  • Biobest receives capital increase from Sofina and some private investorsJones Day advised Biobest Group NV in its capital increase in an amount of €98.5 million with cancellation of preferential subscription rights, subscribed by Sofina SA and by other private investors.
  • Sumitomo Bakelite Europe subsidiary acquires industrial land in Ghent, BelgiumJones Day advised Sumitomo Bakelite Europe NV in the acquisition by subsidiary Vyncolit NV of industrial land at the Vynckier site (Ghent, Belgium) from Gegrond BV.
  • Pandox acquires NH Brussels LouiseJones Day advised Pandox AB in the €35 million acquisition of NH Brussels Louise, a hotel in central Brussels, Belgium.
  • iSTAR Medical enters into strategic alliance with AbbVieJones Day advised iSTAR Medical SA in its strategic alliance with AbbVie (NYSE: ABBV).
  • AIP acquires Aluminium BelgiumJones Day advised American Industrial Partners in the acquisition of 100% of the shares of Aluminium Belgium BV, the parent company which owns Aluminium Duffel, from Ecnavla 8 UK Ltd.
  • Stride.VC participates as lead investor in €10 million Series A financing round of TechWolfJones Day represented Stride.VC LLP as lead investor in the €10 million Series A round of financing of TechWolf, the AI technology startup building the world's foremost platform for large companies to leverage their workforce's skills.
  • Consortium BelGaN Group BV acquires ON Semiconductor Belgium BVJones Day advised the consortium BelGaN Group BV with the acquisition of ON Semiconductor Belgium BV, a subsidiary of Semiconductor Components Industries, LLC, which designs and manufactures semiconductors components.
  • Proxyclick sells company to Condeco SoftwareJones Day advised Proxyclick in the sale of the Company to Condeco Software SRL, a portfolio company of Thoma Bravo.
  • Cowboy raises capital in Series C financing roundJones Day represented Cowboy SA, a Belgian start-up that developed an innovative electric bike for the modern-day commuter, in connection with the issuance of Series C Preferred Stock and a venture debt investment.
  • Fragbite acquires Lucky Kat B.V.Jones Day advised Fragbite Group AB, a global esports and gaming company, in the acquisition of Lucky Kat B.V.
    •

    Prima di procedere all'invio, si prega di notare:

    il contenuto del presente sito web è a scopo esclusivamente informativo e non può essere considerato un parere legale o altro tipo di consulenza professionale. L'invio o la ricezione della presente email non è atta ad instaurare alcun rapporto cliente/avvocato. Le informazioni inviate tramite questa funzione al nostro Studio non saranno coperte da vincolo di riservatezza o confidenzialità fintanto che non ci sia stato conferito e non sia stato da noi accettato un incarico professionale. Inviando il messaggio confermate di aver preso visione e accettato il contenuto di questa informativa.